Assertio therapeutics cafepharma

We believe in serving patients, caretakers and prescribers by developing innovative treatments that seek to address the unmet medical Careers, jobs, students, opportunities

Sage is committed to developing new medicines to treat life-altering CNS disorders

engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions

Migraine Awareness Week - September 6 – 12, 2015 Annual worldwide event created with the goal of generating a wider understanding of migraine as a serious public health issue, its effects on millions of sufferers and to reduce the stigma

The company markets three Find information about Nabriva's novel antibiotic research and product pipeline

(Assertio) is a new name that reflects a new business strategy, mission, vision and values Established new headquarters in Lake Forest, IL Transformed into a leaner, more entrepreneurial and faster moving company Location allows the Company to Avion is a Specialty Pharmaceutical company that develops and markets a growing portfolio of innovative, branded prescription pharmaceutical and dietary supplement products in Women’s Health, Hematology, Dermatology, and related Specialties

Heron Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Court nixes Ampyra patents, teeing up 2018 Amarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health

100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224

ESPERION Therapeutics is not accepting unsolicited assistance from agencies and/or search firms for any job posted on this or a referring site

Nucynta is still positioned for solid growth in the following years desp Assertio Therapeutics, Inc (ASRT) Q4 2018 Earnings Conference Call Transcript Motley Fool Transcribing | Mar 6, 2019 ASRT earnings call for the period ending December 31, 2018

Nabriva is committed to the development of Novel Antibiotics, with pipeline work focusing on Lefamulin and BC-7013

(“Assertio” or the “Company”) (NASDAQ: ASRT), today announced the completion and final results for its cash tender offers (the “Offers”) to purchase any and all of the outstanding $42,465,000 in aggregate principal * assertio therapeutics (asrt) - arthur higgins to become non-executive chairman and todd smith to be named president and ceo of combined company * assertio therapeutics (asrt)- zyla stockholders will receive 2

We’re excited to have a second option available for some Full Profile of EXEL (Exelixis, Inc

View Rodney Johnson’s profile on LinkedIn, the world's largest professional community

We improve the health and well-being of patients around the world

Its brands include Gralise, Zipsor Assertio therapeutics (formerly known as Depomed) develops extended and controlled release small molecule therapeutics by using a gastroretentive polymer formulation

Arbor Pharmaceuticals is an Atlanta, Georgia based specialty pharmaceutical company which markets prescription products for the cardiovascular, hospital, neuroscience and pediatric markets

Patni served as Chief Development Officer at Ocera Therapeutics

That said, though, there’s an interesting discussion going on in the comment section of the IN VIVO blog’s article Don’t Come Knockin’ On My Door

Verastem Oncology Announces Global Licensing Agreement with Chugai Pharmaceutical Co

AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review to Unlock Shareholder Value and Financial Update

NEW YORK, May 8, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Assertio Therapeutics, Inc

More Other News for ASRT Mar 11, 2020 · Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company's core areas of neurology, orphan and specialty medicines

Acorda Therapeutics plans to appeal a court’s recent decision to nix four of its five Ampyra patents

Developing therapies for patients with serious, rare and life-threatening diseases Our mission is to develop innovative treatments to improve the lives of individuals suffering from neuropsychiatric and neurologic disorders in order to reduce the burden on patients and their caregivers

Supernus, a specialty pharmaceutical company with more than 25 years of experience focused on developing products to treat central nervous system diseases

Salaries, reviews, and more - all posted by employees working at TerSera Therapeutics

(NASDAQ: ASRT) and Zyla Life Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium May 22, 2020 · assertio therapeutics inc (asrt): * assertio therapeutics announces first-quarter 2020 results

He previously served on the boards of Crealta Pharmaceuticals, Actient Pharmaceuticals, TAP Pharmaceuticals, Graceway Pharmaceuticals, iBIO, California Healthcare Institute, National Pharmaceutical Council and Allendale Association

Watch to see how kaléo’s values and product development apply this patient-centric mission in order to solve some of the largest health challenges facing this country

Braeburn is committed to the fight against opioid use disorder

NYSEMkt Updated Jun 25, 2019 8:00 PM Athenex Announces Superior Response and Survival with Lower Neuropathy of a Novel Oral Paclitaxel versus IV Paclitaxel in Treatment of Metastatic Breast Cancer

The company has two platform technologies, each with the potential to be developed for multiple indications

At Exelixis, everyone leads in our collective quest to drive for results so patients can have hope for remission

founder John Kapoor, a Boston jury has a new item to consider in a catalog of dubious tactics the company is accused of Merger Agreement

, a Delaware corporation and a wholly-owned subsidiary of Assertio (“Parent”), Alligator Merger Sub, Inc

"I get to wear a lot of different hats in an industry that provides very fast-paced and interesting work Horizon Therapeutics is a biopharmaceutical company that is driven to deliver breakthrough medicines to patients because we understand the challenges they face

Zogenix is committed to developing and commercializing transformative therapies to improve the lives of patients and their families living with rare diseases

17 Mar 2020 March 17 (Reuters) - Assertio Therapeutics Inc: * PRESS RELEASE - ASSERTIO THERAPEUTICS AGREES TO MERGE WITH ZYLA LIFE SCIENCES TO CREATE SYNERGISTIC PORTFOLIO OF NEUROLOGY AND  CafePharma - Pharmaceutical Sales Professionals Frank DeCosta III

We conduct more than 250 studies a year across multiple therapeutic areas and have developed long-standing relationships with a wide range of global sponsors who rely on our Early Phase Research and Clinical Trial Management expertise

AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review More

Assertio currently markets Collegium Pharma to acquire Nucynta franchise from Assertio Therapeutics for $375 million: Lake Forest, Illinois Saturday, February 8, 2020, 13:00 Hrs [IST] Assertio Therapeutics has entered into a definitive agreement with Collegium Pharmaceutical, pursuant to which Collegium will acquire the Nucynta franchise of products from the company

Kaléo is a new type of pharmaceutical company, dedicated to building innovative solutions for serious and life-threatening medical conditions

We are a global pharmaceutical company, proud to be unique in our space as experts in the development and commercialization of safe, novel products that address unmet medical needs through improved dosing and by ensuring the safety and efficacy of our products and product candidates

Our long-acting local analgesic, EXPAREL ® (bupivacaine liposome injectable suspension), is a non-opioid medication administered at the time of Kaléo is a new type of pharmaceutical company, dedicated to building innovative solutions for serious and life-threatening medical conditions

Feb 19, 2019 · The FDA accepts for review Assertio Therapeutic's (NASDAQ:ASRT) marketing application seeking approval for its injectable formulation of long-acting cosyntropin (synthetic adrenocorticotropic hormone, Ed currently serves on the boards of TerSera Therapeutics, Senseonics and Clearbrook

We are building a team of experienced professionals dedicated to addressing the urgent need for food-allergy treatments

Depomed was founded in 1995 and is headquartered in Newark, California

It offers products under the brands of Cometriq, Cabometyx, and Cotellic

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management

Patni brings more than 15 years of global drug development experience across multiple therapeutic areas as well as extensive knowledge of the drug approval process

View detailed financial information, real-time news, videos, quotes and analysis on Assertio Therapeutics Inc

We’re excited to have a second option available for some Assertio Therapeutics, Inc

Ocular Therapeutix is a biopharmaceutical platform company leveraging its formulation expertise to develop transformational drug treatments that enhance people’s lives

Show less Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines

Please browse all of our available job and career opportunities

The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings · The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings

All résumés submitted by an agency and/or search firm to any employee at ESPERION via email, the internet, or in any other form and/or method without a valid written TerSera Therapeutics LLC 520 Lake Cook Road, Suite 500 Deerfield, IL 60015 1-888-600-8116

Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary

If you would like to discuss partnering/business Aquestive is the worldwide leader in delivering trusted, quality medications on oral film

; Investors Are Encouraged To Contact The Firm PR Newswire Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines

Athenex Announces Details of Investor Event and Webcast at SABCS on December 13, 2019

Halozyme is not responsible for or endorses the content of the linked site

The MS community is unique… they’re exceptionally well-educated about their disease, proactive about their health and researching new Currax Pharmaceuticals LLC is a specialty pharmaceutical business focused on acquiring and commercializing prescription drugs within the U

Overreliance on opioids in the postsurgical setting has set off a cascade of negative consequences, ranging from potentially severe adverse events to the risk of long-term use, misuse, and addiction

What's this about? I'm sorry if this is a rookie question, but I wanted to understand

Apply to any positions you believe you are a fit for and contact us today! The average salary for Sales Analytics Specialist I at companies like ASSERTIO THERAPEUTICS INC in the United States is $59,990 as of April 27, 2020, but the salary range typically falls between $53,290 and $67,290

Stock analysis for Assertio Therapeutics Inc (DEPO) including stock price, stock chart, company news, key statistics, fundamentals and company profile

Portola Pharmaceuticals to Webcast Corporate Update on January 14, 2020

Summary Toggle Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019 October 24, 2019 Summary Toggle Melinta Therapeutics Announces U

TerSera Therapeutics LLC, 520 Lake Cook Road, Suite 500, Deerfield, IL 60015 Melinta Therapeutics, Inc

Currax distributes a range of both Branded and generic pharmaceutical products, including Contrave®, Onzetra® Xsail®, Silenor®, Treximet®, Zohydro® ER with BeadTek® and the authorized Acorda Therapeutics, Inc

The core values are a formalized definition of our corporate culture and embody Mar 02, 2020 · Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines

The week aims to encourage people with migraine to seek information and advice and to help those who do not have migraine to understand more about the Assertio Therapeutics, Inc

market therapies We founded Acorda to bring life-changing therapies to people living with a wide range of nervous system disorders The one thing you should know about Acorda Therapeutics is that everything we do is aimed at improving the lives of The Complete List of Biotech Stocks Trading on the NASDAQ as of Feb 22, 2020 are listed below: Note: If you are looking for the Complete List of Biotech stocks on the NYSE, click here

Together with counseling and support, Braeburn’s next generation medicines are developed with an aim to support patients with OUD as they focus on the reintegration of Braeburn is committed to the fight against opioid use disorder

Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability

Assertio currently markets three FDA -approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be Assertio Therapeutics, Inc

Thanks Concentric Analgesics is a private, biotechnology company focused on discovering and developing novel, non-opioid therapeutics for the management of acute postsurgical and chronic osteoarthritis pain

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates The Merger Of Assertio Therapeutics, Inc

Avion focuses on identifying opportunities to acquire and enhance the market potential of innovative OPKO Health, Inc

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Lexicon Pharmaceuticals to Host First Quarter 2020 Financial Results Conference Call and Webcast on April 27, 2020 Lexicon Pharmaceuticals to Host Virtual Annual Meeting of Stockholders on April 23, 2020 LAKE FOREST, Ill

I have a small position with Assertio Therapeutics at DeGiro

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Investor Update Call

is a Vermont Foreign Profit Corporation filed on August 1, 2019

Tolmar offers exciting opportunities that will leverage your abilities, expand your skills, and reward your contributions in an atmosphere that encourages both personal and professional growth

5 shares of common stock of newly-formed holding co for each share of zyla common stock held Assertio Therapeutics to merge with Zyla Life Sciences 03/16/20-9:04AM EST Seeking Alpha Assertio Therapeutics to merge with Zyla Life Sciences 03/16/20-5:46AM EST Thefly

Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain

We trace our roots back to 1909 when Dr Please click here to see Amarin's current opportunities

(ASRT) CEO Arthur Higgins on Q1 2020 Results - Earnings Call Transcript Seeking Alpha 5/11/2020 Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections

“It has been 15 years since a treatment was approved in the U

Compare pay for popular roles and read about the team’s work-life balance

Lundbeck A/S made by executives and their closely associated parties May 12, 2020 ı Corporate Releases Strong momentum across all strategic brands with 35% growth in Q1 2020, financial guidance maintained treatments to help patients with cancer thrive

Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises

Here are the stocks that have soared and sunk the most in 2019 MarketWatch

At ACADIA, we are passionate about improving the lives of patients with central nervous system (CNS) disorders

It develops and markets a product for the treatment in neurology, orphan and diseases of the central nervous system

is responsible for the sales, marketing and distribution of pharmaceutical products within the US

At OPKO Health, we seek to serve unmet patient needs through our first in class products, comprehensive diagnostics laboratories, robust research and development pipeline, and unique pharmaceutical business solutions

Arbor also has several branded prescription products in late-stage development

Amarin’s lead product, VASCEPA ® (icosapent ethyl) capsules, is available by prescription in the United States and an increasing number of other countries

Together with counseling and support, Braeburn’s next generation medicines are developed with an aim to support patients with OUD as they focus on the reintegration of Avanir employees are a diverse team of dedicated, accomplished professionals united by a common purpose: striving to make a change by developing innovative treatments for central nervous system (CNS) conditions

The Vice President of Managed Markets & Trade is responsible for the development, implementation and execution of Restructure Information On September 15, 2019, Purdue announced a preliminary agreement to settle the massive opioid litigation facing the Company

7 Aug 2018 See what employees say it's like to work at TerSera Therapeutics

If you are an energetic self-starter who wants to join a great team and make a difference in the lives of patients, we may have a role for you

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) December 7, 2019

Astellas Pharma brings brighter futures to patients, physicians, communities and employees as a new kind of pharmaceutical company The work we do is guided by people living with rare and devastating diseases

Our lead program (OP0201) is a surfactant-based nasal aerosol drug-device combination Welcome to Merz North America Merz North America is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the US

is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer

It mainly markets products for treatment in neurology, pain and diseases of the central nervous system

Living with a rare disease isn’t just about the treatment, it’s also about channeling uncertainty and fear into something Avadel Pharmaceuticals

Shares of Assertio Therapeutics (NASDAQ:ASRT) rose 9% in pre-market trading after the company reported Q1 results

As you conduct your job search, please beware of the possibility that scammers may post fraudulent job openings or send fraudulent communications such as emails, SMS, WhatsApp or Messenger posts pretending to be from Sanofi

was founded in 1995 and is headquartered in Lake Forest, Illinois

Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance

FDA Grants Fast Track Designation to Arena Pharmaceuticals' APD418 for Development in Decompensated Heart Failure Patients

Assertio currently markets Mar 02, 2020 · Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company's core areas of neurology, orphan and specialty medicines

Get all Latest News about DepoMed, Breaking headlines and Top stories, photos & video in real time Nov 27, 2019 · A chronic skin condition that leads to severe, persistent itching, affecting millions in the U

Message board - Online Community of active, educated investors researching and discussing Melinta Therapeutics, Inc

Feb 13, 2019 · Just over two weeks into the racketeering trial of Insys Therapeutics Inc

market therapies Monday, February 24, 2020 Acorda Therapeutics to Present at Cowen Annual Health Care Conference

(“Assertio” or the “Company”) (NASDAQ: ASRT), today announced the completion and final results for its cash tender offers (the “Offers”) to purchase any and all of the outstanding $42,465,000 in aggregate principal Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines

To implement this settlement and secure a final resolution of all pending litigation, Purdue and its subsidiaries voluntarily filed petitions for reorganization under Chapter 11 of the U

Please provide a link to the article, and do not cut and paste whole articles due to copyright restrictions

We’re developing innovative therapies that have the potential to transform the lives of people with infectious diseases, and our current platform is just the beginning

May 24, 2020 · Assertio Therapeutics Announces Completion and Final Results of the Offer to Purchase All of Its Issued and Outstanding 2

The firm focuses on neurology, orphan and specialty medicines

Attitude, effort and ingenuity can accomplish great things and people who exemplify these traits are the building blocks of Amarin’s success

9 ways COVID-19 may forever upend the US healthcare industry — FDA approves Genentech's Tecentriq as first-line monotherapy for certain people with metastatic NSCLC — 23andMe trying to crack the genetic code behind the coronavirus  8 hours ago Therapeutic Specialties

This formulation allows for decreased dosing, lower toxicity, and improved therapeutic efficacy over traditional formulation

Careers Let’s work together and make the opportunities of today the advances of tomorrow

Acquires North American Product Rights; New Estrogen Inhibitor in Phase II Clinical Development BIOWIRE2K February 05, 2004 08:15 AM Eastern Standard Time Novus Therapeutics is a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT)

Verastem Oncology Presents Phase 2 PRIMO Study Data Evaluating Duvelisib in Alkermes plc is a pharmaceutical manufacturing and biopharmaceutical company developing innovative medicines to help patients with serious chronic conditions

Opioid addiction, also known as opioid use disorder (OUD), is a medical condition requiring medical treatment

Jan 18, 2017 · Cadila Healthcare is set to acquire California-based speciality pharma company Sentynl Therapeutics for $171 million as the company looks for alternative ways to build its US business that has Notice

The Registered Agent on file for this company is Corporation Service Company and is located at 100 N Main St Ste 2, Barre, VT 05641-4150

To date, we have three medicines available to treat certain types of kidney, liver and thyroid cancers and advanced melanoma

We have developed a portfolio of meaningfully differentiated products for use in the treatment of moderate to severe pain

From bench to bedside, a diverse portfolio of investigational compounds across different stages of drug development

Grifols, with more than 24,000 employees in 30 countries and regions, is committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry

We seek to make a positive impact on the unmet treatment needs of patients by advancing product candidates from a robust development pipeline of potential CNS Assertio Therapeutics, Inc

Assertio (ASRT) Reports Q4 Loss, Tops Revenue Estimates Assertio (ASRT) delivered earnings and revenue surprises of -200

Investigational product candidate, ZX008 (low-dose fenfluramine) for the treatment of Lennox-Gastaut syndrome (LGS) Fenfluramine hydrochloride oral solution

, April 08, 2020 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc

Based in Los Altos, CA, Concentric is developing a family of non-opioid therapeutics that provide l VABOMERE ® (meropenem and vaborbactam) is indicated for the treatment of patients 18 years of age and older with complicated urinary tract infections (cUTI) including pyelonephritis caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae species complex

Interested in Joining Our Team? New Name, Renewed Mission: Advance Patient Care in the Company’s Core Areas of Neurology, Orphan & Specialty Medicines 3 Assertio Therapeutics, Inc

Mar 19, 2019 · Assertio Therapeutics Inc has won the dismissal of a shareholder lawsuit accusing it of misleading investors about the extent to which its growth was fueled by marketing its Nucynta opioid Mar 16, 2020 · Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company's core areas of neurology, orphan and specialty medicines

* assertio therapeutics (asrt) - merger with zyla life sciences on track, expected to close shortly after co's 2020 annual meeting

Novum is a full-service CRO with numerous FDA approvals in ANDA and NDA submissions

NASDAQ Updated May 22, 2020 11:23 PM Assertio Therapeutics Announces its Virtual 2020 Annual Meeting on May 19, 2020, and Mailing of its Joint Proxy Statement/Prospectus Merger with Zyla Life Sciences Expected to Close Shortly After the 2020 Annual Meeting Assertio Reaffirms its Ability to Achieve Upwards of $40 Million in Synergies Will Report First Quarter 2020 Financial Results For the most complete and up-to-date information on United Therapeutics' products, please visit each product's individual website

00% Senior Convertible Notes Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines

The company's filing status is listed as Active and its File Number is 0360844

has a collaboration and license agreement with Ironwood Pharmaceuticals, Inc

Get the inside scoop on jobs, salaries, top office locations, and CEO insights

Contact Us 100 South Saunders Road, Suite 300 Lake Forest, IL 60045 Tel: 224

(ACOR) stock quote, history, news and other vital information to help you with your stock trading and investing

Studies establishing effectiveness included Aimmune’s approach to treating food allergies builds on the \u0003oral immunotherapy concept, where the body’s immune system \u0003can be desensitized to certain food allergens by ingesting tiny doses of the specially processed allergen in gradually increasing amounts over time

Flexion Therapeutics is a biopharmaceutical company focused on advancing innovative, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis

We are building the foundation to become a leading biopharmaceutical company dedicated to developing and commercializing innovative therapies in the CNS area

Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA

(ASRT) CEO Arthur Higgins on Q1 2020 Results - Earnings Call Transcript Seeking Alpha 5/11/2020 An ex-stripper who became a regional sales director at Insys Therapeutics Inc gave a doctor a lap dance at a Chicago club as the drugmaker pushed the doctor to prescribe its addictive fentanyl H iguys

(NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic company, today announced the pricing of a public offering of 133,333,333 common shares (or common share equivalents) of the Company, together with warrants to purchase up to 133,333,333 common shares Assertio Therapeutics

Aquestive Therapeutics is the undisputed leader in Ronit Milstein, MBA

It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines

Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be GlobeNewswire 31d: Assertio Therapeutics Announces Completion and Final Results of the Offer to Purchase All of Its Issued and Outstanding 2

See the complete profile on LinkedIn and discover Rodney’s Syneos Health is the only fully integrated biopharmaceutical solutions organization

Do the numbers hold clues to what lies ahead for the stock? Assertio Therapeutics, Inc

and hear what the News Headlines for Assertio Therapeutics Inc

Every medicine is different, so Aquestive follows a drug-by-drug approach for harnessing PharmFilm® technology to achieve target product profiles and clinical improvement goals

10 Pharma/Biotech Companies - In the News For the discussion of current news articles in the pharma/biotech space

Karyopharm Therapeutics is an innovation-driven pharmaceutical company focused on the discovery, development, and commercialization of medicines with the goal of improving the lives of patients with cancer

The first medication from Dermira is designed Assertio Therapeutics, Inc

a Delaware corporation (“Assertio”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Zyla Life Sciences, a Delaware corporation (“Zyla”), Alligator Zebra Holdings, Inc

Uncover why Assertio Therapeutics is the best company for you

Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales

FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP) Tolmar is a pharmaceutical company focused on the development, approval and commercialization of specialty pharmaceutical products in the therapeutic areas of urology and oncology

Interested in Joining Our Team? Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance

, based in Grand Cayman, develops novel therapeutics by leveraging its proprietary Mar 19, 2020 · Assertio Therapeutics announced Wednesday it will merge with Pennsylvania-based Zyla Life Sciences, creating a new commercial pharmaceutical company with neurology, inflammation and pain products

The level of professionalism in online forums leaves a little to be desired

Company Name: Assertio Therapeutics INC, Stock Symbol: ASRT, Industry: Biotechs, Total Posts: 115, Last Post: 5/21/2020 12:04:29 AM If you’ve read this blog for long, you know my views on CafePharma

We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives

Senior Neuroscience Area Manager Long Term Care at Avanir Pharmaceuticals

(the "Company") received notification (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company's common stock is subject to potential delisting from the Nasdaq Global Find out what works well at Assertio Therapeutics from the people who know best

Our products are distributed through two divisions: Aesthetics and Neurosciences

Amicus Therapeutics is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases

Assertio currently markets two FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved Feb 19, 2019 · Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines

Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities

Jan 24, 2017 · Depomed’s share price has suffered lately due to rumors of a low buyout offer from KKR

of scandal-plagued pharmas rehabbing their reputations with a name change · Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change

If you are interested in helping define an emerging therapeutic space and working to make a profound difference in the lives of people with food allergies, please view our list of current opportunities

Assertio Therapeutics Announces First-Quarter 2020 Results GlobeNewswire

Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million